Evidence map›Paper›PMID 42527437›Full record

ArticleScientific reports2026

A hybrid ConvNeXt-ViT framework with differential evolution optimization for breast cancer classification.

Murdhy A Aldawsari, Saad Jamhan Aldosari, Atef Ismail, Marwa M Emam

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Murdhy A AldawsariDepartment of Mathematics, College of Sciences and Humanities, Prince Sattam Bin Abdulaziz University, Al-Kharj, 11942, Saudi Arabia.
Saad Jamhan AldosariDepartment of Mathematics, College of Sciences and Humanities, Prince Sattam Bin Abdulaziz University, Al-Kharj, 11942, Saudi Arabia.
Atef IsmailPhysics Department, Al-Azhar University, Asyut, 71524, Egypt.
Marwa M EmamFaculty of Computers and Information, Minia University, Minia, Egypt. marwa.khalef@mu.edu.eg.ORCID 0000-0001-7399-6839

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer, a leading cause of mortality among women worldwide, necessitates early detection through mammography. Yet, automated classification remains challenging due to class imbalance, limited datasets, and the need for both local and global feature extraction. While convolutional neural networks (CNNs) excel in local feature extraction for mammogram classification, they struggle with long-range contextual dependencies. Conversely, transformer-based models capture global relationships effectively but require large datasets and substantial computational resources, limiting their applicability in medical imaging. To overcome these limitations, we propose DEViTNeXt, a new hybrid framework that synergistically combines ConvNeXt's convolutional efficiency with Vision Transformer (ViT) attention-based global modeling, enhanced by Differential Evolution (DE) optimization. The framework employs comprehensive preprocessing (Gaussian filtering, CLAHE enhancement) and a hybrid augmentation pipeline that integrates GAN-based synthesis of malignant cases with geometric transformations. Dual-branch feature extraction leverages ConvNeXt for hierarchical local features and ViT for global contextual relationships, with Multi-Head Attention (MHA) refinement dynamically emphasizing diagnostic regions in both branches. A DE-optimized MHA fusion layer adaptively integrates complementary. A composite loss function (Weighted Cross-Entropy + Focal Loss) addresses class imbalance while focusing on complex malignant cases. Extensive experiments on the CBIS-DDSM and MIAS datasets demonstrate DEViTNeXt's superiority, achieving 99.63% accuracy, 99.45% sensitivity, and 99.55% specificity on CBIS-DDSM under binary (Benign vs. Malignant) classification, and 98.50% accuracy on MIAS (3-class), outperforming state-of-the-art methods.

Indexed as

Breast NeoplasmsMammographyAlgorithmsClassification AlgorithmsConvolutional Neural NetworksFemaleHumansBreast cancer classificationConvNeXtDifferential evolutionGenerative adversarial networksMulti-head attentionVision transformer

Identifiers

PMID42527437
PMCPMC13421594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.